SCHEMBL7748732

SCHEMBL7748732

Cc1ccc(S(=O)(=O)ONC(=N)NN=Cc2ccc(O)cc2O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCOA1 Q15788 1/20 0.49
NCOA3 Q9Y6Q9 1/20 0.49
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
POLB P06746 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
ALPL P05186 1/20 0.48
ALPI P09923 1/20 0.48
ALPG P10696 1/20 0.48
EIF4H Q15056 1/20 0.48
MAPT P10636 5/20 0.44
GAA P10253 2/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
HSD17B3 P37058 1/20 0.42
HSD17B2 P37059 1/20 0.42
NTRK1 P04629 1/20 0.42
RAB9A P51151 3/20 0.41
NPC1 O15118 2/20 0.41
KDM4E B2RXH2 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7747548 0.83 LMNA (0.48) MEN1KMT2AL3MBTL1MAPTGAA
SCHEMBL916511 0.81 NCOA1 (0.50) NCOA1NCOA3MEN1KMT2APOLB
SCHEMBL916509 0.81 NCOA1 (0.50) NCOA1NCOA3MEN1KMT2APOLB
SCHEMBL7748726 0.80 ALDH1A1 (0.49) MEN1KMT2APOLBMAPTGAA
SCHEMBL916513 0.80 NCOA1 (0.49) NCOA1NCOA3MEN1KMT2APOLB
SCHEMBL7748727 0.80 NCOA1 (0.51) NCOA1NCOA3MEN1KMT2APOLB
SCHEMBL7748730 0.80 NCOA1 (0.51) NCOA1NCOA3MEN1KMT2APOLB
SCHEMBL7748694 0.76 MEN1 (0.48) MEN1KMT2APOLBL3MBTL1MAPT
SCHEMBL7750407 0.76 KMT2A (0.58) MEN1KMT2APOLBL3MBTL1MAPT
SCHEMBL7743109 0.75 MAPT (0.51) MEN1KMT2APOLBMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2001025192-A1 GUANIDINE DERIVATIVES AND THEIR USE IN THE PRODUCTION OF A MEDICAMENT FOR BLOCKING XANTHINE OXIDASE/DEHYDROGENASE MELACURE THERAPEUTICS AB (SE) 2001-04-12 WO disclosed